Quest Diagnostics Incorporated (DGX)
NYSE: DGX · IEX Real-Time Price · USD
136.10
-1.46 (-1.06%)
May 2, 2024, 1:38 PM EDT - Market open
Quest Diagnostics Employees
Quest Diagnostics had 48,000 employees on December 31, 2023. The number of employees decreased by 1,000 or -2.04% compared to the previous year.
Employees
48,000
Change (1Y)
-1,000
Growth (1Y)
-2.04%
Revenue / Employee
$193,479
Profits / Employee
$17,625
Market Cap
15.12B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 48,000 | -1,000 | -2.04% |
Dec 31, 2022 | 49,000 | 0 | - |
Dec 31, 2021 | 49,000 | 0 | - |
Dec 31, 2020 | 49,000 | 2,000 | 4.26% |
Dec 31, 2019 | 47,000 | 1,000 | 2.17% |
Dec 31, 2018 | 46,000 | 1,000 | 2.22% |
Dec 31, 2017 | 45,000 | 2,000 | 4.65% |
Dec 31, 2016 | 43,000 | -1,000 | -2.27% |
Dec 31, 2015 | 44,000 | -1,000 | -2.22% |
Dec 31, 2014 | 45,000 | 4,000 | 9.76% |
Dec 31, 2013 | 41,000 | 0 | - |
Dec 31, 2012 | 41,000 | -1,000 | -2.38% |
Dec 31, 2011 | 42,000 | 0 | - |
Dec 31, 2010 | 42,000 | -1,000 | -2.33% |
Dec 31, 2009 | 43,000 | 200 | 0.47% |
Dec 31, 2008 | 42,800 | -700 | -1.61% |
Dec 31, 2007 | 43,500 | 2,500 | 6.10% |
Dec 31, 2006 | 41,000 | -500 | -1.20% |
Dec 31, 2005 | 41,500 | 2,900 | 7.51% |
Dec 31, 2004 | 38,600 | 1,400 | 3.76% |
Dec 31, 2003 | 37,200 | 3,800 | 11.38% |
Dec 31, 2002 | 33,400 | 4,400 | 15.17% |
Dec 31, 2001 | 29,000 | 2,000 | 7.41% |
Dec 31, 2000 | 27,000 | 0 | - |
Dec 31, 1999 | 27,000 | 12,000 | 80.00% |
Dec 31, 1998 | 15,000 | -1,300 | -7.98% |
Dec 31, 1997 | 16,300 | -1,500 | -8.43% |
Dec 31, 1996 | 17,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Walgreens Boots Alliance | 331,000 |
Laboratory Corporation of America Holdings | 67,000 |
Viatris | 38,000 |
Teva Pharmaceutical | 37,851 |
The Cooper Companies | 15,000 |
Revvity | 11,500 |
BeiGene | 10,600 |
Hologic | 6,990 |
DGX News
- 1 day ago - Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI - PRNewsWire
- 2 days ago - FDA brings lab tests under federal oversight in bid to improve accuracy and safety - Market Watch
- 9 days ago - Quest Diagnostics raises 2024 profit and revenue forecast on strong demand - Reuters
- 9 days ago - Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024 - PRNewsWire
- 10 days ago - Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease - PRNewsWire
- 4 weeks ago - Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay - PRNewsWire
- 5 weeks ago - Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease - PRNewsWire
- 6 weeks ago - Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024 - PRNewsWire